Stockscreener 앱 받기
1.48
3.27%
-0.05
전일 마감가:
$1.53
열려 있는:
$1.51
하루 거래량:
528.68K
Relative Volume:
0.31
시가총액:
$569.16M
수익:
$106.34M
순이익/손실:
$-74.66M
주가수익비율:
-1.5579
EPS:
-0.95
순현금흐름:
$-46.12M
1주 성능:
-1.99%
1개월 성능:
+7.25%
6개월 성능:
+5.71%
1년 성능:
-5.73%
1일 변동 폭
$1.4542
$1.53
1주일 범위
$1.4542
$1.6699
52주 변동 폭
$0.92
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.48 | 588.39M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-27 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Standard BioTools (NASDAQ:LAB) versus Clover Health Investments (NASDAQ:CLOV) Critical Review - Defense World
Chipmakers Recap: Can Standard BioTools Inc stock double in the next yearJuly 2025 Highlights & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug Outlook: Will Standard BioTools Inc stock recover after earningsPortfolio Growth Summary & Fast Entry High Yield Tips - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) shareholders have endured a 76% loss from investing in the stock five years ago - Yahoo Finance
Death Cross: Is Sunshine Biopharma Incs ROE strong enoughEarnings Growth Report & Stock Portfolio Risk Management - baoquankhu1.vn
The Truth About SomaLogic Inc: Is This Quiet Biotech About To Blow Up Or Fade Out? - AD HOC NEWS
Sumitomo Mitsui Trust Group Inc. Sells 773,708 Shares of Standard BioTools Inc. $LAB - MarketBeat
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools - Intellectia AI
Standard BioTools Inc. (LAB) Stock Analysis: Navigating a Challenging Market with Innovative Technologies - DirectorsTalk Interviews
Sentiment Recap: Why Standard BioTools Inc stock could rally in 20252025 Growth vs Value & Trade Opportunity Analysis - Bộ Nội Vụ
Standard BioTools (NASDAQ:LAB) Trading 5.6% HigherStill a Buy? - MarketBeat
Why Standard BioTools Inc. stock could outperform in 2025Market Growth Summary & AI Powered Market Trend Analysis - ulpravda.ru
Will Standard BioTools Inc. stock benefit from green energy trendsPortfolio Risk Report & Reliable Intraday Trade Alerts - Улправда
User | woonsocketcall.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - FinancialContent
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - Sahm
Can Standard BioTools Inc. stock maintain operating marginsLayoff News & Expert-Curated Trade Recommendations - Улправда
Will Standard BioTools Inc. (FLB) stock rise with strong economyJuly 2025 Catalysts & Low Risk High Reward Ideas - Улправда
Is Standard BioTools Inc. stock a buy before product launchesMarket Risk Summary & High Accuracy Investment Signals - ulpravda.ru
Standard BioTools (NASDAQ:LAB) Shares Gap UpShould You Buy? - MarketBeat
Standard BioTools Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2025 - marketscreener.com
Standard BioTools Reports Preliminary Q4, Full-Year Revenue - Nasdaq
Standard BioTools (NASDAQ:LAB) & Hinge Health (NYSE:HNGE) Critical Contrast - Defense World
What analysts say about Standard BioTools Inc stockExit Strategy Tips & Investment Portfolio Recommendations - earlytimes.in
User | theeveningleader.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - markets.financialcontent.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 80% - simplywall.st
Standard BioTools: Outlook Still Murky (NASDAQ:LAB) - Seeking Alpha
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% – Here’s Why - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1%What's Next? - MarketBeat
What Standard BioTools Inc.'s (NASDAQ:LAB) 28% Share Price Gain Is Not Telling You - 富途牛牛
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9% – What’s Next? - Defense World
With Standard BioTools Stock Surging, Have You Considered The Downside? - Trefis
Can Standard BioTools Inc. stock sustain market leadershipWeekly Profit Summary & Detailed Earnings Play Alerts - Улправда
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9%Time to Sell? - MarketBeat
Is Standard BioTools Inc. stock a top pick in earnings seasonIndex Update & Reliable Intraday Trade Alerts - Bölüm Sonu Canavarı
Is Standard BioTools Inc. (FLB) stock bottoming after sell offWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
Will Standard BioTools Inc. stock outperform growth indexesBreakout Watch & Expert Verified Movement Alerts - Улправда
Is Standard BioTools Inc. stock a safe investment in uncertain markets2025 Buyback Activity & Safe Entry Zone Tips - ulpravda.ru
Analysts Set Standard BioTools Inc. (NASDAQ:LAB) Price Target at $1.35 - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Zacks Research - MarketBeat
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - setenews.com
Should investors be concerned about Standard BioTools Inc (LAB)? - uspostnews.com
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 75,000 Shares - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Purchases 125,000 Shares of Stock - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Acquires 150,000 Shares of Stock - MarketBeat
Standard BioTools Inc. Stock (LAB) Opinions on Insider Purchases - Quiver Quantitative
Subdued Growth No Barrier To Standard BioTools Inc. (NASDAQ:LAB) With Shares Advancing 26% - simplywall.st
Will Standard BioTools Inc. stock attract ESG investorsQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
Why Standard BioTools Inc. (FLB) stock is upgraded to buy2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
0.96%
자본화:
|
볼륨(24시간):